Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease

[1]  D. Schlessinger,et al.  Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[2]  P. Deyn,et al.  Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia , 2013, Alzheimer's & Dementia.

[3]  Shunichiro Shinagawa,et al.  Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease. , 2013, Biochemical and biophysical research communications.

[4]  Constantine G Lyketsos,et al.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[5]  H. Yoon,et al.  Plasma Brain-derived Neurotrophic Factor in Hemodialysis Patients , 2012, International journal of medical sciences.

[6]  Shunichiro Shinagawa,et al.  Association between BDNF Polymorphism (Val66Met) and Executive Function in Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer Disease , 2012, Dementia and Geriatric Cognitive Disorders.

[7]  Zhijun Zhang,et al.  Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls , 2012, Human Genetics.

[8]  H. Arai,et al.  Genetic Association between Ghrelin Polymorphisms and Alzheimer’s Disease in a Japanese Population , 2011, Dementia and Geriatric Cognitive Disorders.

[9]  B. Diniz,et al.  Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and Beyond , 2011, NeuroMolecular Medicine.

[10]  G. Knudsen,et al.  Blood BDNF concentrations reflect brain-tissue BDNF levels across species. , 2011, The international journal of neuropsychopharmacology.

[11]  A. Morozov,et al.  BDNF‐restricted knockout mice as an animal model for aggression , 2011, Genes, brain, and behavior.

[12]  B. Pollock,et al.  The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. , 2011, Archives of general psychiatry.

[13]  S. O'Bryant,et al.  Serum Brain-Derived Neurotrophic Factor Levels Are Specifically Associated with Memory Performance among Alzheimer’s Disease Cases , 2010, Dementia and Geriatric Cognitive Disorders.

[14]  O. Forlenza,et al.  Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[15]  Shunichiro Shinagawa,et al.  Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with Alzheimer's disease , 2009, International Psychogeriatrics.

[16]  Matthias L. Schroeter,et al.  Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients , 2009, NeuroImage.

[17]  C. Caltagirone,et al.  Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression , 2009, Neurobiology of Aging.

[18]  C. Caltagirone,et al.  Alzheimer'S disease (ad) and mild cognitive impairment (mci) patients are characterized by increased bdnf serum levels , 2009, Alzheimer's & Dementia.

[19]  B. Ham,et al.  Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. , 2009, Alcohol.

[20]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[21]  D. Geschwind,et al.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.

[22]  H. Danker-Hopfe,et al.  Higher BDNF concentrations in the hippocampus and cortex of an aggressive mouse strain , 2009, Behavioural Brain Research.

[23]  S. Waring,et al.  Brain-derived neurotrophic factor levels in Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[24]  Felipe Fregni,et al.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.

[25]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[26]  A. Benitez,et al.  Serum Brain-Derived Neurotrophic Factor Is Associated With Cognitive Function in Healthy Older Adults , 2008, Journal of geriatric psychiatry and neurology.

[27]  Annalena Venneri,et al.  Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[28]  Zhijun Zhang,et al.  Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. , 2008, The Journal of clinical psychiatry.

[29]  G. Knudsen,et al.  Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels , 2008, Experimental Neurology.

[30]  C. Martini,et al.  Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. , 2008, Journal of affective disorders.

[31]  G. Knudsen,et al.  Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. , 2008, Experimental neurology.

[32]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[33]  Hongwei Song,et al.  The Val66Met polymorphism of the brain‐derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[34]  E. Teng,et al.  Neuropsychiatric Symptoms Are Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[35]  N. Hirono,et al.  Caregiver Burden Associated with Behavioral and Psychological Symptoms of Dementia in Elderly People in the Local Community , 2007, Dementia and Geriatric Cognitive Disorders.

[36]  S. Poduslo,et al.  Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease , 2006, Journal of Medical Genetics.

[37]  S. Shimohama,et al.  Variations in the BDNF Gene in Autopsy-Confirmed Alzheimer’s Disease and Dementia with Lewy Bodies in Japan , 2006, Dementia and Geriatric Cognitive Disorders.

[38]  M. Bartels,et al.  Stage-dependent BDNF serum concentrations in Alzheimer’s disease , 2006, Journal of Neural Transmission.

[39]  S. Tsakiris,et al.  Serotoninergic impairment and aggressive behavior in Alzheimer's disease. , 2005, Acta neurobiologiae experimentalis.

[40]  H. Arai,et al.  Brain-derived neurotrophic factor gene polymorphisms and Alzheimer’s disease , 2005, Journal of Neural Transmission.

[41]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[42]  Paresh D Patel,et al.  Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons , 2004, The Journal of Neuroscience.

[43]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[44]  D. Murman,et al.  The incremental direct costs associated with behavioral symptoms in AD , 2002, Neurology.

[45]  C. Naranjo,et al.  Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease , 2002, Neuropsychopharmacology.

[46]  Ruoyan Chen,et al.  Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation , 2002, Thrombosis and Haemostasis.

[47]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[48]  I Litvan,et al.  The FAB: A frontal assessment battery at bedside , 2000, Neurology.

[49]  C. Wihler,et al.  Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Aghajanian,et al.  5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex , 1997, The Journal of Neuroscience.

[51]  S H Ferris,et al.  Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. , 1987, The Journal of clinical psychiatry.

[52]  T. Crow,et al.  The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia , 1986, Neurobiology of Aging.

[53]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[54]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[55]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.